Lipid abnormalities in red blood cell and plasma phospholipids in cyclosporine-treated heart transplant recipients

Transplant Proc. 1994 Dec;26(6):3722-6.

Authors

P G Phair¹, H R Powell, D A McCredie

Affiliation

¹ Department of Nephrology, Royal Children's Hospital, Parkville, Victoria, Australia.

PMID: 7998329

No abstract available

Publication types

Clinical Trial
Controlled Clinical Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Arachidonic Acid / blood
Child
Child, Preschool
Creatinine / blood
Cyclosporine / adverse effects*
Cyclosporine / blood
Erythrocytes / metabolism*
Fatty Acids, Nonesterified / blood
Heart Transplantation / immunology
Heart Transplantation / physiology*
Hemolytic-Uremic Syndrome / blood
Humans
Hyperlipidemias / blood*
Hyperlipidemias / chemically induced
Phospholipids / blood*
Reference Values

Substances

Fatty Acids, Nonesterified
Phospholipids
Arachidonic Acid
Cyclosporine
Creatinine